While Leap Therapeutics Inc has underperformed by -2.73%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LPTX fell by -14.74%, with highs and lows ranging from $4.79 to $1.68, whereas the simple moving average jumped by 25.52% in the last 200 days.
On June 28, 2024, Rodman & Renshaw started tracking Leap Therapeutics Inc (NASDAQ: LPTX) recommending Buy. A report published by Mizuho on October 04, 2021, Initiated its previous ‘Buy’ rating for LPTX. Robert W. Baird also rated LPTX shares as ‘Outperform’, setting a target price of $5 on the company’s shares in an initiating report dated June 04, 2021. Piper Sandler Initiated an Overweight rating on June 29, 2020, and assigned a price target of $6. Robert W. Baird initiated its ‘Outperform’ rating for LPTX, as published in its report on February 11, 2020. Raymond James also rated the stock as ‘Outperform’.
Analysis of Leap Therapeutics Inc (LPTX)
One of the most important indicators of Leap Therapeutics Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -106.79% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.97, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and LPTX is recording 381.81K average volume. On a monthly basis, the volatility of the stock is set at 8.38%, whereas on a weekly basis, it is put at 8.81%, with a gain of 17.74% over the past seven days. Furthermore, long-term investors anticipate a median target price of $9.38, showing growth from the present price of $3.38, which can serve as yet another indication of whether LPTX is worth investing in or should be passed over.
How Do You Analyze Leap Therapeutics Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 25.44%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 31.82% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
LPTX shares are owned by institutional investors to the tune of 31.82% at present.
